Dhar, S. S., Brown, C., Rizvi, A., Reed, L., Kotla, S., Zod, C., . . . Lee, M. G. Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of LSD1 and OXPHOS. Elsevier.
Chicago Style (17th ed.) CitationDhar, Shilpa S., et al. Heterozygous Kmt2d Loss Diminishes Enhancers to Render Medulloblastoma Cells Vulnerable to Combinatory Inhibition of LSD1 and OXPHOS. Elsevier.
MLA (9th ed.) CitationDhar, Shilpa S., et al. Heterozygous Kmt2d Loss Diminishes Enhancers to Render Medulloblastoma Cells Vulnerable to Combinatory Inhibition of LSD1 and OXPHOS. Elsevier.
Warning: These citations may not always be 100% accurate.